Evidence map›Paper›PMID 42771547›Full record

ArticleRevista medica del Instituto Mexicano del Seguro Social2026

[Association between anthropometric clinical predictors and HOMA-IR].

Laura Navarrete-Cortes, Rey David Sánchez-Morales, Imer Guillermo Herrera-Olvera, Aldo Ferreira-Hermosillo, Espiridión Ramos-Martínez

Abstract readComparative StudyEnglish Abstract
In one paragraph

Article in Revista medica del Instituto Mexicano del Seguro Social, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Laura Navarrete-CortesInstituto Mexicano del Seguro Social, Unidad de Medicina Familiar No. 75, Consulta Externa. Ciudad Nezahualcóyotl, Estado de México, México.ORCID 0009-0000-9926-5591
Rey David Sánchez-MoralesInstituto Mexicano del Seguro Social, Unidad de Medicina Familiar No. 75, Coordinación Clínica de Enseñanza e Investigación en Salud. Ciudad Nezahualcóyotl, Estado de México, México.ORCID 0009-0004-5407-7270
Imer Guillermo Herrera-OlveraInstituto Mexicano del Seguro Social, Unidad de Medicina Familiar No. 75, Coordinación Clínica de Enseñanza e Investigación en Salud. Ciudad Nezahualcóyotl, Estado de México, México.ORCID 0000-0003-0239-1781
Aldo Ferreira-HermosilloInstituto Mexicano del Seguro Social, Centro Médico Nacional Siglo XXI, Hospital de Especialidades "Dr. Bernardo Sepúlveda Gutiérrez", Unidad de Investigación Médica en Enfermedades Endocrinas. Ciudad de México, México.ORCID 0000-0002-5159-9856
Espiridión Ramos-MartínezUniversidad Nacional Autónoma de México, Facultad de Medicina, Unidad de Medicina Experimental. Ciudad de México, México.ORCID 0000-0002-4361-821X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: The HOMA-IR index is a test that identifies the early risk of developing type 2 diabetes mellitus (T2DM) by measuring insulin resistance (IR); however, these tests are not readily available in primary care settings. Predictors of IR, such as body mass index (BMI) and waist-to-hip ratio (WHR), are useful for the early detection of this risk. Objective: To associate anthropometric parameters with HOMA-IR, considering BMI. Material and methods: A cross-sectional, comparative study was conducted. Serum glucose and insulin concentrations were determined using non-probability convenience sampling and the difference of proportions formula to calculate the HOMA-IR index in 315 adults without diabetes. Anthropometric parameters and visceral fat were considered, and participants were divided into groups according to BMI: normal weight, overweight, and obesity. Differences between groups were determined by Kruskal-Wallis test and the risk of each variable through multiple logistic regression. Results: Of the 315 participants, 57% showed IR; most of them belonged to the overweight and obesity group. Serum insulin concentrations and IR differed significantly among the 3 BMI groups, primarily in the overweight and obesity groups. WHR is a good predictor of risk for IR. Conclusions: IR can be early detected by using validated indices such as HOMA-IR. At the primary care level, anthropometric parameters such as WHR can be used, as it has proven to be a better predictor of IR, phenomenon that occurs much earlier than hyperglycemia.

Indexed as

Body Mass IndexDiabetes Mellitus, Type 2Insulin ResistanceWaist-Hip RatioAdultBlood GlucoseCross-Sectional StudiesFemaleHumansInsulinMaleMiddle AgedObesityOverweightPredictive Value of TestsRisk FactorsBlood GlucoseInsulinBody Mass IndexHOMA-IRÍndice Cintura-CaderaÍndice de Masa CorporalInsulin ResistanceResistencia a la InsulinaWaist-to-Hip Ratio

Identifiers

PMID42771547
PMCPMC13600744

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.